These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33102223)

  • 41. The clinical results of pediatric brain tumors treated with Linac-based stereotactic radiosurgery and radiotherapy.
    Puataweepong P; Dhanachai M; Dangprasert S; Narkwong L; Sitathanee C; Junwityanujit T
    J Med Assoc Thai; 2012 Nov; 95(11):1466-71. PubMed ID: 23252214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases.
    Johannwerner L; Werner EM; Janssen S; Yu NY; Rades D
    Anticancer Res; 2023 Jun; 43(6):2757-2762. PubMed ID: 37247897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes for Pituitary Adenoma Patients Treated with Linac- Based Stereotactic Radiosurgery and Radiotherapy: a Long Term Experience in Thailand.
    Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Sitathanee C; Swangsilpa T; Vitoonpanich P; Yongvithisatid P
    Asian Pac J Cancer Prev; 2015; 16(13):5279-84. PubMed ID: 26225666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial.
    Diehl CD; Shiban E; Straube C; Gempt J; Wilkens JJ; Oechsner M; Kessel C; Zimmer C; Wiestler B; Meyer B; Combs SE
    Cancer Commun (Lond); 2019 Nov; 39(1):73. PubMed ID: 31706337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases.
    Rana N; Pendyala P; Cleary RK; Luo G; Zhao Z; Chambless LB; Cmelak AJ; Attia A; Stavas MJ
    Front Oncol; 2017; 7():279. PubMed ID: 29218301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme.
    Cho KH; Hall WA; Lo SS; Dusenbery KE
    Technol Cancer Res Treat; 2004 Feb; 3(1):41-9. PubMed ID: 14750892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
    Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
    World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis.
    Balducci M; Autorino R; Chiesa S; Mattiucci G; Pompucci A; Azario L; D'Agostino GR; Ferro M; Fiorentino A; Fersino S; Mazzarella C; Colosimo C; Frascino V; Anile C; Valentini V
    Anticancer Res; 2015 May; 35(5):3055-9. PubMed ID: 25964595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of stereotactic radiosurgery, hypofractionated, and fractionated stereotactic radiotherapy in the treatment of skull base meningioma.
    Han J; Girvigian MR; Chen JC; Miller MJ; Lodin K; Rahimian J; Arellano A; Cahan BL; Kaptein JS
    Am J Clin Oncol; 2014 Jun; 37(3):255-60. PubMed ID: 23241504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials.
    Lehrer EJ; Peterson JL; Zaorsky NG; Brown PD; Sahgal A; Chiang VL; Chao ST; Sheehan JP; Trifiletti DM
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):618-630. PubMed ID: 30395902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linear accelerator-based single-fraction stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy for intact and resected brain metastases up to 3 cm: A multi-institutional retrospective analysis.
    Diamond BH; Jairam V; Zuberi S; Li JY; Marquis TJ; Rutter CE; Park HS
    J Radiosurg SBRT; 2021; 7(3):179-187. PubMed ID: 33898081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-centre experience of stereotactic radiosurgery and fractionated stereotactic radiotherapy for prolactinomas with the linear accelerator.
    Wilson PJ; Williams JR; Smee RI
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):371-8. PubMed ID: 25410143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Staged Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy in Patients with Brain Metastases > 2 cm without Prior Whole Brain Radiotherapy: A Systematic Review and Meta-Analysis.
    Harikar MM; Venkataram T; Palmisciano P; Scalia G; Baldoncini M; Cardali SM; Umana GE; Ferini G
    World Neurosurg; 2023 Oct; 178():213-232.e6. PubMed ID: 37543203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peri-radiosurgical administration of bevacizumab improves radiographic response to single and fractionated stereotactic radiosurgery for large brain metastasis.
    Chen YL; Huang AP; Wang CC; Chen HY; Chen YF; Xiao F; Lu SL; Cheng JC; Hsu FM
    J Neurooncol; 2021 Jul; 153(3):455-465. PubMed ID: 34100178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases.
    Yamada T; Ohtakara K; Kamomae T; Itoh J; Shimada H; Ishihara S; Naganawa S
    Cureus; 2022 Jun; 14(6):e25888. PubMed ID: 35844334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.
    Raleigh DR; Seymour ZA; Tomlin B; Theodosopoulos PV; Berger MS; Aghi MK; Geneser SE; Krishnamurthy D; Fogh SE; Sneed PK; McDermott MW
    J Neurosurg; 2017 Jun; 126(6):1749-1755. PubMed ID: 27367240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereotactic radiosurgery and radiotherapy for acoustic neuromas.
    Kalogeridi MA; Kougioumtzopoulou A; Zygogianni A; Kouloulias V
    Neurosurg Rev; 2020 Jun; 43(3):941-949. PubMed ID: 30982152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.